HOLX Hologic Inc

$67.04

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending
Expected on
Report Time: Unknown Release Time
The Whisper Number
Consensus Estimate:
Revenue Estimate:

Latest Earnings Insight

Updated On 10/2/2025

About Hologic Inc

Hologic, Inc. is a medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.

Website: https://www.hologic.com

Sector
LIFE SCIENCES
Industry
X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS
Exchange
NASDAQ
Country
USA
Currency
USD
Fiscal Year End
September
CIK
859737
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA, US
Valuation
Market Cap
$12.99B
P/E Ratio
18.22
PEG Ratio
1.26
Price to Book
2.71
Performance
EPS
$3.16
Dividend Yield
Profit Margin
18.40%
ROE
15.80%
Technicals
50D MA
$62.01
200D MA
$73.95
52W High
$84.67
52W Low
$55.89
Fundamentals
Shares Outstanding
226M
Target Price
$76.03
Beta
0.83

HOLX EPS Estimates vs Actual

Estimated
Actual

HOLX News & Sentiment

Oct 01, 2025 • Zacks Commentary BULLISH
HOLX vs. IDXX: Which Stock Is the Better Value Option?
Investors with an interest in Medical - Instruments stocks have likely encountered both Hologic ( HOLX Quick QuoteHOLX - ) and Idexx Laboratories ( IDXX Quick QuoteIDXX - ) . But which of these two companies is the best option for those looking for undervalued stocks? Let's take a closer look.
Oct 01, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Hologic Bets on Endomagnetics to Fuel Interventional Breast Momentum
HOLX's Interventional Breast business hits $100M as Endomag products boost recurring revenues and margins.
Sep 30, 2025 • Zacks Commentary BULLISH
Why Hologic ( HOLX ) is a Top Momentum Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Sep 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
QuidelOrtho Expands Portfolio With the Launch of FDA-Approved Test
QDEL boosts its respiratory testing lineup with the FDA-cleared QUICKVUE Influenza + SARS Test for professional use.
Sep 30, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Hologic, Inc. ( HOLX ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Sep 29, 2025 • Benzinga SOMEWHAT-BULLISH
Volition Signs Co-Marketing and Services Agreement with Hologic - Hologic ( NASDAQ:HOLX ) , VolitionRX ( AMEX:VNRX )
HENDERSON, Nev., Sept. 29, 2025 /PRNewswire/ -- VolitionRx Limited ( NYSE: VNRX ) ( "Volition" ) , a multi-national epigenetics company, today announces that it has signed an agreement with Hologic Diagenode ( "Hologic" ) for the co-marketing of Volition's Nu.Q® Discover service.
Sentiment Snapshot

Average Sentiment Score:

0.241
50 articles with scored sentiment

Overall Sentiment:

Bullish

HOLX Reported Earnings

May 01, 2025
Mar 31, 2025 (Post market)
0.01 Surprise
  • Reported EPS: $1.03
  • Estimate: $1.02
  • Whisper:
  • Surprise %: 1.4%
Feb 05, 2025
Dec 31, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $1.03
  • Estimate: $1.02
  • Whisper:
  • Surprise %: 1.0%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.0 Surprise
  • Reported EPS: $1.01
  • Estimate: $1.01
  • Whisper:
  • Surprise %: 0.0%
Jul 29, 2024
Jun 30, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $1.06
  • Estimate: $1.02
  • Whisper:
  • Surprise %: 3.9%
May 02, 2024
Mar 31, 2024 (Post market)
0.05 Surprise
  • Reported EPS: $1.03
  • Estimate: $0.98
  • Whisper:
  • Surprise %: 5.1%
Feb 01, 2024
Dec 31, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.98
  • Estimate: $0.95
  • Whisper:
  • Surprise %: 3.2%
Nov 09, 2023
Sep 30, 2023 (Post market)
0.05 Surprise
  • Reported EPS: $0.89
  • Estimate: $0.84
  • Whisper:
  • Surprise %: 6.0%
Jul 31, 2023
Jun 30, 2023 (Post market)
0.04 Surprise
  • Reported EPS: $0.93
  • Estimate: $0.89
  • Whisper:
  • Surprise %: 4.5%
May 01, 2023
Mar 31, 2023 (Post market)
0.18 Surprise
  • Reported EPS: $1.06
  • Estimate: $0.88
  • Whisper:
  • Surprise %: 20.4%

Financials